Secretoneurin as a novel cardiovascular biomarker and potential therapeutic strategy
SN is a prognostic biomarker in CVD, and unraveling the underlying pathophysiology of SN will be important to advance SN as a biomarker and potential future therapy in CVD. The future for SN as a biomarker and therapy is attractive and could be of future clinical relevance.
Authors
- Helge Rørvik Røsjø (ORCID: https://orcid.org/0000-0003-2114-3134)
- Anett H. Ottesen
- Torbjørn Omland (ORCID: https://orcid.org/0000-0002-6452-0369)
Institutions
- University of Oslo (NO)
- Akershus University Hospital (NO)
Publication Details
- Journal
- Expert Review of Cardiovascular Therapy
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1080/14779072.2025.2604574
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00